From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with Hemophilia A with or without inhibitors (FRONTIER2)

Disease Areas
Congresses
Scientific Publications
IME

Search Science Hub

Register Login

My Account

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Congresses
ASH 2025
From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with Hemophilia A with or without inhibitors (FRONTIER2)